NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CB Therapeutics

CB Therapeutics

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://cbthera.com/

Last Round

Series A

May 10, 2021

Total Funding Raised

$370,000

Company Overview

CB Therapeutics is a synthetic biology company that designs, develops, and manufactures high-value molecules through precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clean Manufacturing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

precision fermentationsynthetic biologysynbiobiomanufacturingbioactive moleculesdrug discoveryai-driven biologybioinformaticstherapeutic peptidesstrain engineeringbiosynthesisalkaloid therapeuticsbiotech platformcontract manufacturingcdmo

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CB Therapeutics Comparables

Compare CB Therapeutics with similar companies based on industry and business-model similarity.

CB Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellibre
87%
Khona Scientific, Inc.
83%
Biomedican
82%

CB Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 10, 2021
DebtMay 3, 2020
AcceleratorAug 1, 2018
AcceleratorJul 25, 2017

Key People

Founding team and executive leadership

Jacob Vogan

Co-Founder And Chief Scientific Officer (CSO)

Founding Team

Sher Ali Butt

CoFounder, CEO, Board Member

Founding Team

CB Therapeutics Investors

Notable investors and investment history

CB Therapeutics investors
InvestorRounds
re.Mind CapitalSeries A
EvoNexusAccelerator
305 VenturesAccelerator
Y CombinatorAccelerator
Healthspan CapitalAccelerator
Rebel FundAccelerator

CB Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CB Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CB Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range14
Year Founded2015
Last FundingMay 10, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.